Patent Oppositions in organic medicines industry

Explore the competitive field of organic medicines where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in organic medicines technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Last updated on: Sep 3, 2026
CompanyTotal Oppositions
NOVARTIS346
BOEHRINGER INGELHEIM159
PFIZER102
NUTRICIA99
CELGENE83
EURO CELTIQUE71
NESTLE69
F HOFFMANN LA ROCHE65
NESTEC63
GILEAD SCIENCES62

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the organic medicines industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the organic medicines industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Sep 3, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Solid Dosage Forms And Dosing Regimens Comprising (2R,3S,4S,5R)-4-[[3-(3,4-Difluoro-2-Methoxy-Phenyl)-4,5-Dimethyl-5-(Trifluoromethyl) Tetrahydrofuran-2-Carbonyl]Amino]Pyridine-2-CarboxamideVERTEX PHARMACEUTICALS INCORPORATEDSep 3, 2026BARDEHLE PAGENBERG
Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole For Use As A MedicamentPFIZERSep 3, 2026HOLLATZ
Vitamin And Mineral Softgel Capsule Preparations Comprising Vitamin C In The Form Of An Ascorbate SaltBAYER CONSUMER CARESep 2, 2026NESTLE
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 2, 2026BARDEHLE PAGENBERG
Solid Dosage Forms And Dosing Regimens Comprising (2R,3S,4S,5R)-4-[[3-(3,4-Difluoro-2-Methoxy-Phenyl)-4,5-Dimethyl-5-(Trifluoromethyl) Tetrahydrofuran-2-Carbonyl]Amino]Pyridine-2-CarboxamideVERTEX PHARMACEUTICALS INCORPORATEDSep 2, 2026DEVA
Crystalline Solid Forms Of 6-Carboxy-2-(3,5-Dichlorophenyl)-Benzoxazole For Use As A MedicamentPFIZERSep 2, 2026DEVA HOLDING
Sglt-2 Inhibitor For Treating Type 1 Diabetes Mellitus, Type 2 Diabete Mellitus, Impaired Glucose Tolerance Or HyperglycemiaBOEHRINGER INGELHEIMAug 26, 2026ADALVO
Bi-Layer Pharmaceutical Tablet FormulationVIIV HEALTHCAREAug 26, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD
Combination Comprising An Mek Inhibitor And A B-Raf InhibitorNOVARTISAug 26, 2026HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
Sglt-2 Inhibitor For Treating Type 1 Diabetes Mellitus, Type 2 Diabete Mellitus, Impaired Glucose Tolerance Or HyperglycemiaBOEHRINGER INGELHEIMAug 25, 2026DEVA HOLDING ANONIM SIRKETI

To stay ahead in the competitive organic medicines industry, companies are constantly innovating. Here are the top patents facing oppositions in the organic medicines industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Sep 3, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Oct 12, 2022S1P Receptor Modulators For Treating Multiple SclerosisNOVARTIS23
Apr 14, 2021Methods And Compositions For Treating CancerCOUGAR BIOTECHNOLOGY22
Nov 6, 2024Dosing Regimen Associated With Long Acting Injectable Paliperidone EstersJANSSEN PHARMACEUTICA20
Nov 26, 2025Sglt-2 Inhibitor For Treating Type 1 Diabetes Mellitus, Type 2 Diabete Mellitus, Impaired Glucose Tolerance Or HyperglycemiaBOEHRINGER INGELHEIM19
Oct 23, 2024New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTIS19
Jan 17, 2024Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM18
Mar 8, 2023Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTIS17
Oct 11, 2023New UseNOVARTIS16
Jan 16, 2019(+)-2-[1-(3-Ethoxy-4-Methoxyphenyl)-2-Methylsulfonylethyl]-4-Acetylaminoisoindoline-1,3-Dione: Methods Of Using And Compositions ThereofAMGEN EUROPE15
Apr 22, 2015Prevention And Treatment Of Thromboembolic DisordersBAYER HEALTHCARE15